Summit Technology (BEAM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Summit Technology (BEAM)

BEAM 25.01

+5.1%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Riverlightning who wrote (1369)	12/8/1999 10:43:00 PM
From: Carl R.	Read Replies (1) of 1386

I didn't say it was right or wrong. I said that that was what an analyst said. I should have provided a link. Sorry. biz.yahoo.com Here is the quote: Kate Sharadin, senior analyst, and associate analyst Jason Mills believe the ITC ruling that Nidek does not infringe or violate certain of VISX patents, coupled with said patents validity being called into question weakens Summit's market position by virtue of the fact that the Company's royalty-free cross licensing arrangement to VISX patents could prove to be less valuable to a potential suitor. Carl

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next